211 related articles for article (PubMed ID: 7913700)
1. Genetic stability of Borrelia burgdorferi recovered from chronically infected immunocompetent mice.
Persing DH; Mathiesen D; Podzorski D; Barthold SW
Infect Immun; 1994 Aug; 62(8):3521-7. PubMed ID: 7913700
[TBL] [Abstract][Full Text] [Related]
2. Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks.
Ohnishi J; Piesman J; de Silva AM
Proc Natl Acad Sci U S A; 2001 Jan; 98(2):670-5. PubMed ID: 11209063
[TBL] [Abstract][Full Text] [Related]
3. Taxonomic classification of 29 Borrelia burgdorferi strains isolated from patients with Lyme borreliosis: a comparison of five different phenotypic and genotypic typing schemes.
Lebech AM; Hansen K; Wilske B; Theisen M
Med Microbiol Immunol; 1994 Dec; 183(6):325-41. PubMed ID: 7541107
[TBL] [Abstract][Full Text] [Related]
4. Variation in the size of the ospA-containing linear plasmid, but not the linear chromosome, among the three Borrelia species associated with Lyme disease.
Samuels DS; Marconi RT; Garon CF
J Gen Microbiol; 1993 Oct; 139(10):2445-9. PubMed ID: 8254314
[TBL] [Abstract][Full Text] [Related]
5. Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen.
Probert WS; LeFebvre RB
Infect Immun; 1994 May; 62(5):1920-6. PubMed ID: 8168958
[TBL] [Abstract][Full Text] [Related]
6. Selection of variant Borrelia burgdorferi isolates from mice immunized with outer surface protein A or B.
Fikrig E; Tao H; Barthold SW; Flavell RA
Infect Immun; 1995 May; 63(5):1658-62. PubMed ID: 7729870
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous implanted chambers in different mouse strains as an animal model to study genetic stability during infection with Lyme disease Borrelia.
Jonsson M; Elmros T; Bergström S
Microb Pathog; 1995 Feb; 18(2):109-14. PubMed ID: 7543971
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of genetic divergence among Borrelia burgdorferi isolates by use of OspA, fla, HSP60, and HSP70 gene probes.
Wallich R; Helmes C; Schaible UE; Lobet Y; Moter SE; Kramer MD; Simon MM
Infect Immun; 1992 Nov; 60(11):4856-66. PubMed ID: 1356932
[TBL] [Abstract][Full Text] [Related]
9. Protective immunization with plasmid DNA containing the outer surface lipoprotein A gene of Borrelia burgdorferi is independent of an eukaryotic promoter.
Simon MM; Gern L; Hauser P; Zhong W; Nielsen PJ; Kramer MD; Brenner C; Wallich R
Eur J Immunol; 1996 Dec; 26(12):2831-40. PubMed ID: 8977275
[TBL] [Abstract][Full Text] [Related]
10. Immune sera to individual Borrelia burgdorferi isolates or recombinant OspA thereof protect SCID mice against infection with homologous strains but only partially or not at all against those of different OspA/OspB genotype.
Schaible UE; Wallich R; Kramer MD; Gern L; Anderson JF; Museteanu C; Simon MM
Vaccine; 1993; 11(10):1049-54. PubMed ID: 8212826
[TBL] [Abstract][Full Text] [Related]
11. Consensus sequence on the genes encoding the major outer surface proteins (OspA and OspB) of Borrelia garinii isolate.
Wang J; Masuzawa T; Komikado T; Yanagihara Y
Microbiol Immunol; 1997; 41(2):83-91. PubMed ID: 9087950
[TBL] [Abstract][Full Text] [Related]
12. Temporal pattern of Borrelia burgdorferi p21 expression in ticks and the mammalian host.
Das S; Barthold SW; Giles SS; Montgomery RR; Telford SR; Fikrig E
J Clin Invest; 1997 Mar; 99(5):987-95. PubMed ID: 9062357
[TBL] [Abstract][Full Text] [Related]
13. Genetic heterogeneity of Borrelia burgdorferi in the United States.
Mathiesen DA; Oliver JH; Kolbert CP; Tullson ED; Johnson BJ; Campbell GL; Mitchell PD; Reed KD; Telford SR; Anderson JF; Lane RS; Persing DH
J Infect Dis; 1997 Jan; 175(1):98-107. PubMed ID: 8985202
[TBL] [Abstract][Full Text] [Related]
14. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties.
Ma Y; Weis JJ
Infect Immun; 1993 Sep; 61(9):3843-53. PubMed ID: 8359905
[TBL] [Abstract][Full Text] [Related]
15. Comparison of protection in rabbits against host-adapted and cultivated Borrelia burgdorferi following infection-derived immunity or immunization with outer membrane vesicles or outer surface protein A.
Shang ES; Champion CI; Wu XY; Skare JT; Blanco DR; Miller JN; Lovett MA
Infect Immun; 2000 Jul; 68(7):4189-99. PubMed ID: 10858236
[TBL] [Abstract][Full Text] [Related]
16. An ospA frame shift, identified from DNA in Lyme arthritis synovial fluid, results in an outer surface protein A that does not bind protective antibodies.
Fikrig E; Liu B; Fu LL; Das S; Smallwood JI; Flavell RA; Persing DH; Schoen RT; Barthold SW; Malawista SE
J Immunol; 1995 Dec; 155(12):5700-4. PubMed ID: 7499856
[TBL] [Abstract][Full Text] [Related]
17. Protective immunity is induced by a Borrelia burgdorferi mutant that lacks OspA and OspB.
Hughes CA; Engstrom SM; Coleman LA; Kodner CB; Johnson RC
Infect Immun; 1993 Dec; 61(12):5115-22. PubMed ID: 8225588
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphism of the gene encoding the outer surface protein A (OspA) of Borrelia burgdorferi.
Zumstein G; Fuchs R; Hofmann A; Preac-Mursic V; Soutschek E; Wilske B
Med Microbiol Immunol; 1992; 181(2):57-70. PubMed ID: 1406458
[TBL] [Abstract][Full Text] [Related]
19. Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi OspA or B.
Fikrig E; Tao H; Chen M; Barthold SW; Flavell RA
J Clin Invest; 1995 Oct; 96(4):1706-14. PubMed ID: 7560061
[TBL] [Abstract][Full Text] [Related]
20. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease.
Wallich R; Siebers A; Jahraus O; Brenner C; Stehle T; Simon MM
Infect Immun; 2001 Apr; 69(4):2130-6. PubMed ID: 11254567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
